dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 12, 2026

Trump tariffs live updates: US explores new tariffs in investigation targeting trading partners

View original at finance.yahoo.com
Trump tariffs live updates: US explores new tariffs in investigation targeting trading partners The US is pursuing new tariffs on nations with which it trades, pivoting after the Supreme Court struck down President Trump's most sweeping tariffs under the International Emergency Economic Powers Act (IEEPA)…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Electronic refund process will be ready within 45 days

    60% confidence
  • US economic growth was muted in February as tariffs increased costs for businesses, some of which passed along higher prices to consumers

    60% confidence
  • Importers would receive only one payment from Treasury Department, regardless of how many items or declarations they filed

    60% confidence
  • Customs agency cannot comply with federal judge's order to automatically refund importers' tariff payments without their requesting the refunds

    60% confidence
  • 15% global tariff could begin sometime this week

    60% confidence
  • US businesses and consumers have paid for tariffs, pushing up inflation

    60% confidence
  • Trump administration's tariff refund delay is theft in broad daylight

    60% confidence

Data points we hold from this source

Donald Trump · tariff revenue decline1 USD
Donald Trump · planned global tariff rate15 percent
Donald Trump · current global tariff rate10 percent
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Trump tariffs live updates: US explores new tariffs in investigation targeting trading partners: Source | Via News | fr.via.news